Hostname: page-component-5c6d5d7d68-xq9c7 Total loading time: 0 Render date: 2024-08-07T22:19:02.375Z Has data issue: false hasContentIssue false
  • English
  • Français

Technique and long-term results of the semi-implantable transcutaneous bone conduction hearing device Sophono

Presenting Author: Ralf Siegert

Published online by Cambridge University Press:  03 June 2016

Ralf Siegert
Ralf Siegert*
Affiliation:
Prosper-Hospital
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstracts
Information
The Journal of Laryngology & Otology , Volume 130 , Supplement S3: Abstracts for the 10th International Conference on Cholesteatoma , May 2016 , pp. S87 - S88
Copyright
Copyright © JLO (1984) Limited 2016 

Learning Objectives:

Introduction: Patients with air bone gaps can be treated with bone conducting hearing aids. The disadvantages of the conventional and percutaneous systems are the obvious external fixation components or the biological and psychosocial problems of open implants. This project was set up to develop a semi-implantable transcutaneous bone conducting device, introduce it into clinical application and follow-up on the results.

Material and Method: The principle of this bone conducting device is the magnetic coupling between implanted and external magnets. After extensive lab tests it was introduced clinically in 2006. Since then there have been performed more than 300 implantations in Recklinghausen and more than 3000 worldwide.

Results and Conclusions: The operative technique is relatively simple. With the new “Up-Side-Down-Technique” bone does not have to be removed at all anymore. The 2.6 mm thin implants are hardly palpable. The hearing improvement is similar to other bone conducting hearing aids. This semi-implantable transcutaneous bone conduction hearing device is another option for patients with CSOM, air-bone-gaps, mixed hearing loss or single sided deafness.